Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2026-05-26 @ 4:01 AM
Study NCT ID:
NCT01681433
Status:
TERMINATED
Last Update Posted:
2022-07-11
First Post:
2012-09-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
Sponsor:
Costantine Albany
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GU12-159
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None